a-PiHP

a-PiHP: Research Chemical Properties, Effects, and Legal Status

a-PiHP (alpha-Pyrrolidinoisohexanophenone) is a synthetic stimulant in the pyrrolidinophenone class, closely related to compounds such as α-PVP and a-PHP. It is studied primarily in forensic and analytical laboratories for its structural and behavioral similarity to other stimulant cathinones.

Though it has occasionally appeared in grey-market contexts, a-PiHP is not intended for human consumption and should only be handled by qualified professionals in research settings.

What is a-PiHP?

a-PiHP is a chemical analog of α-PHP, distinguished by a branched isohexyl side chain, which may influence its pharmacokinetics and receptor binding affinity. This compound is often studied for its interaction with the dopamine and norepinephrine transporters, similar to other cathinone derivatives.

  • IUPAC Name: 1-phenyl-2-(pyrrolidin-1-yl)isohexan-1-one

  • Molecular Formula: C16H23NO

  • Class: Pyrrolidinophenone, substituted cathinone

  • Common Form: Crystalline powder

Its structure suggests high lipophilicity and CNS (central nervous system) activity, though no formal clinical trials have been published.

Reported Effects (Speculative and Anecdotal)

There is limited scientific literature on a-PiHP, but anecdotal research reports and community discussions suggest it may produce stimulant effects similar to those seen with α-PVP and other second-generation cathinones. Reported effects include:

  • Physical and mental stimulation

  • Increased alertness and focus

  • Reduced appetite

  • Mild euphoria or mood enhancement

  • Possible compulsion to redose

These effects are speculative and based on unverified self-reports. No clinical data is available to confirm safety, dose-response relationships, or duration.

Safety Profile and Research Handling

a-PiHP should be treated with caution due to its close structural relationship to other high-risk cathinones. Potential safety concerns may include:

  • Tachycardia (rapid heart rate)

  • Hypertension (elevated blood pressure)

  • Anxiety or restlessness

  • Overstimulation or agitation

  • Unknown long-term neurological effects

This substance should only be handled in certified laboratories by trained personnel using appropriate safety measures and PPE (personal protective equipment). a-PiHP is not suitable for consumption or therapeutic use.

Legal Status of a-PiHP

The legal status of a-PiHP varies by jurisdiction, but due to its similarity to other regulated pyrrolidinophenones, many countries classify it under analog or psychoactive substance laws.

  • United States: Not specifically scheduled, but may fall under the Federal Analog Act

  • United Kingdom: Likely restricted under the Psychoactive Substances Act

  • Germany: Controlled under the NpSG (New Psychoactive Substances Act)

  • European Union: Under review in several member states

  • Canada, Australia, China: May be classified under analog or synthetic stimulant bans

Researchers must ensure compliance with local and international regulations before handling, acquiring, or transporting this compound.

For Research Use Only

All information presented here is for scientific, forensic, and educational use only. a-PiHP is not intended for human or veterinary consumption and must only be used in laboratory settings by qualified professionals. Improper use may result in serious legal and health consequences.

Shopping Cart